Advances in top-down proteomics for disease biomarker discovery

David Calligaris1, Claude Villard, Daniel Lafitte

  • 1INSERM UMR 911, Centre de Recherche en Oncologie biologique et en Oncopharmacologie, Aix-Marseille Université, Plateforme Protéomique et Innovation Technologique Timone, Faculté de Pharmacie, 27 Boulevard Jean Moulin, 13385 Marseille Cedex 5, France.

Journal of Proteomics
|April 12, 2011
PubMed
Summary

Top-down mass spectrometry enables protein and post-translational modification analysis for disease biomarker discovery. This review covers methods and applications in clinical biochemistry and proteomics.